Literature DB >> 17000667

Curcumin inhibits neurotensin-mediated interleukin-8 production and migration of HCT116 human colon cancer cells.

Xiaofu Wang1, Qingding Wang, Kirk L Ives, B Mark Evers.   

Abstract

PURPOSE: Neurotensin, a gut tridecapeptide, acts as a potent cellular mitogen for various colorectal and pancreatic cancers that possess high-affinity neurotensin receptors. Cytokine/chemokine proteins are increasingly recognized as important local factors that play a role in the metastasis and invasion of multiple cancers. The purpose of this study was to (a) determine the effect of neurotensin on cytokine/chemokine gene expression and cell migration in human cancer cells and (b) assess the effect of curcumin, a natural dietary product, on neurotensin-mediated processes. EXPERIMENTAL
DESIGN: The human colorectal cancer, HCT116, was treated with neurotensin, with or without curcumin, and interleukin (IL)-8 expression and protein secretion was measured. Signaling pathways, which contribute to the effects of neurotensin, were assessed. Finally, the effect of curcumin on neurotensin-mediated HCT116 cell migration was analyzed.
RESULTS: We show that neurotensin, acting through the native high-affinity neurotensin receptor, induced IL-8 expression in human colorectal cancer cells in a time- and dose-dependent fashion. This stimulation involves Ca2+-dependent protein kinase C, extracellular signal-regulated kinase-dependent activator protein-1, and extracellular signal-regulated kinase-independent nuclear factor-kappaB pathways. Curcumin inhibited neurotensin-mediated activator protein-1 and nuclear factor-kappaB activation and Ca2+ mobilization. Moreover, curcumin blocked neurotensin-stimulated IL-8 gene induction and protein secretion and, at a low concentration (i.e., 10 micromol/L), blocked neurotensin-stimulated colon cancer cell migration.
CONCLUSIONS: Neurotensin-mediated induction of tumor cell IL-8 expression and secretion may contribute to the procarcinogenic effects of neurotensin on gastrointestinal cancers. Furthermore, a potential mechanism for the chemopreventive and chemotherapeutic effects of curcumin on colon cancers may be through the inhibition of gastrointestinal hormone (e.g., neurotensin)-induced chemokine expression and cell migration.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17000667      PMCID: PMC2613866          DOI: 10.1158/1078-0432.CCR-06-0968

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  48 in total

1.  Site-specific DNA methylation contributes to neurotensin/neuromedin N expression in colon cancers.

Authors:  Z Dong; X Wang; B M Evers
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2000-12       Impact factor: 4.052

2.  New and known symmetrical curcumin derivatives inhibit the formation of Fos-Jun-DNA complex.

Authors:  Eun-Ryeong Hahm; Gyo Cheon; Juhyung Lee; Bonjoong Kim; Chihoon Park; Chul-Hak Yang
Journal:  Cancer Lett       Date:  2002-10-08       Impact factor: 8.679

3.  Activation and role of mitogen-activated protein kinases in deoxycholic acid-induced apoptosis.

Authors:  D Qiao; E D Stratagouleas; J D Martinez
Journal:  Carcinogenesis       Date:  2001-01       Impact factor: 4.944

4.  Curcumin, a molecule that inhibits the Ca2+-ATPase of sarcoplasmic reticulum but increases the rate of accumulation of Ca2+.

Authors:  M J Logan-Smith; P J Lockyer; J M East; A G Lee
Journal:  J Biol Chem       Date:  2001-10-09       Impact factor: 5.157

5.  Curcumin: a new cell-permeant inhibitor of the inositol 1,4,5-trisphosphate receptor.

Authors:  J L Dyer; S Zafar Khan; J G Bilmen; S R Hawtin; M Wheatley; M-ul-H Javed; F Michelangeli
Journal:  Cell Calcium       Date:  2002-01       Impact factor: 6.817

6.  Signal transduction pathways mediating neurotensin-stimulated interleukin-8 expression in human colonocytes.

Authors:  D Zhao; A C Keates; S Kuhnt-Moore; M P Moyer; C P Kelly; C Pothoulakis
Journal:  J Biol Chem       Date:  2001-09-26       Impact factor: 5.157

Review 7.  Interleukin-8 and human cancer biology.

Authors:  K Xie
Journal:  Cytokine Growth Factor Rev       Date:  2001-12       Impact factor: 7.638

Review 8.  Interleukin 8 (IL-8) and the release of leukocytes from the bone marrow.

Authors:  S F van Eeden; T Terashima
Journal:  Leuk Lymphoma       Date:  2000-04

9.  Molecular interpretation of ERK signal duration by immediate early gene products.

Authors:  Leon O Murphy; Sallie Smith; Rey-Huei Chen; Diane C Fingar; John Blenis
Journal:  Nat Cell Biol       Date:  2002-08       Impact factor: 28.824

10.  Curcumin inhibits interleukin 8 production and enhances interleukin 8 receptor expression on the cell surface:impact on human pancreatic carcinoma cell growth by autocrine regulation.

Authors:  Hideki Hidaka; Takatoshi Ishiko; Takashi Furuhashi; Hidenobu Kamohara; Shunji Suzuki; Masashi Miyazaki; Osamu Ikeda; Seiji Mita; Toshiaki Setoguchi; Michio Ogawa
Journal:  Cancer       Date:  2002-09-15       Impact factor: 6.860

View more
  41 in total

1.  Absence of neurotensin attenuates intestinal dysbiosis and inflammation by maintaining Mmp7/α-defensin axis in diet-induced obese mice.

Authors:  Jing Li; Xian Li; Jun Song; Baoxiang Yan; Stephanie A Rock; Jianhang Jia; Jinpeng Liu; Chi Wang; Todd Weiss; Heidi L Weiss; Tianyan Gao; Ashfaqul Alam; B Mark Evers
Journal:  FASEB J       Date:  2020-05-02       Impact factor: 5.191

2.  Curcumin prevents leptin raising glucose levels in hepatic stellate cells by blocking translocation of glucose transporter-4 and increasing glucokinase.

Authors:  Youcai Tang; Anping Chen
Journal:  Br J Pharmacol       Date:  2010-11       Impact factor: 8.739

3.  Curcumin inhibits proliferation of colorectal carcinoma by modulating Akt/mTOR signaling.

Authors:  Sara M Johnson; Pat Gulhati; Isela Arrieta; Xiaofu Wang; Tatsuo Uchida; Tianyan Gao; B Mark Evers
Journal:  Anticancer Res       Date:  2009-08       Impact factor: 2.480

4.  Neurotensin signaling activates microRNAs-21 and -155 and Akt, promotes tumor growth in mice, and is increased in human colon tumors.

Authors:  Kyriaki Bakirtzi; Maria Hatziapostolou; Iordanes Karagiannides; Christos Polytarchou; Savina Jaeger; Dimitrios Iliopoulos; Charalabos Pothoulakis
Journal:  Gastroenterology       Date:  2011-07-30       Impact factor: 22.682

Review 5.  "Spicing up" of the immune system by curcumin.

Authors:  Ganesh Chandra Jagetia; Bharat B Aggarwal
Journal:  J Clin Immunol       Date:  2007-01-09       Impact factor: 8.317

6.  Estrogen receptor β potentiates the antiproliferative effect of raloxifene and affects the cell migration and invasion in HCT-116 colon cancer cells.

Authors:  Zhenzhen Tu; Yuxiang Ma; Junmei Tian; Hui Li; Walter Akers; Samuel Achilefu; Yueqing Gu
Journal:  J Cancer Res Clin Oncol       Date:  2012-03-08       Impact factor: 4.553

7.  Therapeutic potential of curcumin in gastrointestinal diseases.

Authors:  Sigrid A Rajasekaran
Journal:  World J Gastrointest Pathophysiol       Date:  2011-02-15

8.  Triptolide inhibits proliferation and migration of colon cancer cells by inhibition of cell cycle regulators and cytokine receptors.

Authors:  Sara M Johnson; Xiaofu Wang; B Mark Evers
Journal:  J Surg Res       Date:  2009-08-05       Impact factor: 2.192

9.  Neurotensin signaling induces intracellular alkalinization and interleukin-8 expression in human pancreatic cancer cells.

Authors:  Ulrike Olszewski; Gerhard Hamilton
Journal:  Mol Oncol       Date:  2009-02-03       Impact factor: 6.603

10.  Cooperative regulation of non-small cell lung carcinoma angiogenic potential by macrophage migration inhibitory factor and its homolog, D-dopachrome tautomerase.

Authors:  Arlixer M Coleman; Beatriz E Rendon; Ming Zhao; Ming-Wei Qian; Richard Bucala; Dan Xin; Robert A Mitchell
Journal:  J Immunol       Date:  2008-08-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.